Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05101460 · ClinicalTrials.gov registry record
An All Comers Registry For Normothermic Ex Vivo Lung Perfusion (EVLP) as Assessment of Donor Lungs for Transplant
A clinical trial of Lung Transplant, sponsored by XVIVO Perfusion.
- Recruiting
- Registry status
- 315
- Enrollment target
- 1
- Study location
NCT05101460 is a study of Lung Transplant that is actively recruiting participants, run by XVIVO Perfusion. The registered enrollment target is 315 participants, below the 1,255-participant average among 15 other Lung Transplant trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05101460, a study of Lung Transplant, is actively recruiting participants, sponsored by XVIVO Perfusion.
- RECRUITING
- Registry status
- 315 participants
- Enrollment target
- 1
- Study location
Study Summary
The XVIVO Registry is to collect standard of care clinical data from "all-comers" who are transplanted with an EVLP lung treated with the XVIVO Perfusion System™ in order to assess the long-term performance of the device, and monitor device-related serious adverse events. In addition, 4 and 5-year UNOS registry data of the 126 subjects who received an EVLP transplant under the NOVEL and NOVEL Extension studies are provided as part of the long-term safety and quality of life data. In addition, 4 and 5-year UNOS registry data of the 126 subjects who received an EVLP transplant under the NOVEL and NOVEL Extension studies are provided as part of the long-term safety and quality of life data.
Conditions Studied
Interventions
- DEVICE XVIVO Perfusion System (XPS™) with STEEN Solution™
Study Locations (1)
Ohio
- Cleveland Clinic Foundation - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 315 participants |
| Start Date | 2019-10-29 |
| Est. Completion | 2029-04-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05101460
The ClinicalTrials.gov registry entry for NCT05101460 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 315 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,255-participant average among 15 other Lung Transplant trials with a reported enrollment target (75% lower). The listed sponsor is XVIVO Perfusion, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lung Transplant appearing as the primary indexed condition, and to 1 intervention - of which XVIVO Perfusion System (XPS™) with STEEN Solution™ is the first listed.
NCT05101460 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05101460 about?
NCT05101460 is a clinical study titled "An All Comers Registry For Normothermic Ex Vivo Lung Perfusion (EVLP) as Assessment of Donor Lungs for Transplant". The XVIVO Registry is to collect standard of care clinical data from "all-comers" who are transplanted with an EVLP lung treated with the XVIVO Perfusion System™ in order to assess the long-term performance of the device, and monitor device-related serious adverse events. In addition, 4 and 5-year U...
What is the current status of trial NCT05101460?
This trial is currently recruiting. The enrollment target is 315 participants. The study started on 2019-10-29. Estimated completion is 2029-04-24.
What conditions does trial NCT05101460 study?
This clinical trial studies the following conditions: Lung Transplant.
What interventions are being tested in trial NCT05101460?
The interventions under investigation include: XVIVO Perfusion System (XPS™) with STEEN Solution™ (DEVICE).
Who is sponsoring clinical trial NCT05101460?
This trial is sponsored by XVIVO Perfusion, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05101460 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Transplant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies
RECRUITING
-
Pre-transplant Health Coaching to Improve Patient-Reported Outcomes in Lung Transplant Candidates
RECRUITING · NA
-
Planned Semi-Elective Lung Tx Study
RECRUITING · NA
-
Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
RECRUITING · Phase 2
-
Tocilizumab in Lung Transplantation
RECRUITING · Phase 2
-
A Study of Latin Dance for Post- Lung Transplant
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.